Ascendis Pharma A/S (ASND)
263.97
+2.74
(+1.05%)
USD |
NASDAQ |
Sep 11, 16:00
263.97
0.00 (0.00%)
After-Hours: 20:00
Ascendis Pharma Price : 263.97 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 10, 2026 | 260.00 | 262.17 | 258.01 | 261.23 | 505041.0 |
| Sep 09, 2026 | 270.89 | 272.37 | 260.75 | 260.81 | 497435.0 |
| Sep 08, 2026 | 263.41 | 272.47 | 262.32 | 270.09 | 653372.0 |
| Sep 04, 2026 | 267.96 | 271.14 | 265.22 | 270.56 | 723516.0 |
| Sep 03, 2026 | 266.94 | 272.44 | 265.80 | 271.12 | 1.019M |
| Sep 02, 2026 | 261.39 | 268.71 | 257.52 | 267.31 | 418296.0 |
| Sep 01, 2026 | 261.65 | 266.63 | 256.28 | 260.25 | 610604.0 |
| Aug 31, 2026 | 247.65 | 268.98 | 247.65 | 263.04 | 1.026M |
| Aug 28, 2026 | 248.11 | 250.23 | 246.30 | 247.91 | 314793.0 |
| Aug 27, 2026 | 249.73 | 250.69 | 248.41 | 249.36 | 189535.0 |
| Aug 26, 2026 | 252.84 | 252.84 | 249.16 | 250.25 | 237428.0 |
| Aug 25, 2026 | 253.01 | 256.60 | 251.32 | 252.99 | 333518.0 |
| Aug 24, 2026 | 256.35 | 256.35 | 247.03 | 251.95 | 329924.0 |
| Aug 21, 2026 | 253.62 | 257.88 | 252.87 | 253.29 | 363774.0 |
| Aug 20, 2026 | 256.65 | 260.98 | 253.21 | 254.81 | 533645.0 |
| Aug 19, 2026 | 255.00 | 261.61 | 251.11 | 259.62 | 541222.0 |
| Aug 18, 2026 | 246.47 | 253.55 | 245.68 | 248.85 | 452633.0 |
| Aug 17, 2026 | 246.33 | 250.62 | 242.00 | 247.40 | 607654.0 |
| Aug 14, 2026 | 243.63 | 249.52 | 240.64 | 248.50 | 650359.0 |
| Aug 13, 2026 | 250.38 | 251.43 | 244.12 | 246.23 | 1.061M |
| Aug 12, 2026 | 253.92 | 258.54 | 251.92 | 255.46 | 440053.0 |
| Aug 11, 2026 | 256.70 | 258.48 | 252.26 | 254.57 | 418491.0 |
| Aug 10, 2026 | 255.01 | 257.42 | 251.00 | 255.62 | 423479.0 |
| Aug 07, 2026 | 251.76 | 257.57 | 251.76 | 255.41 | 325562.0 |
| Aug 06, 2026 | 244.70 | 254.98 | 244.70 | 249.85 | 746643.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Evaxion AS | 3.17 |
| BioMarin Pharmaceutical, Inc. | 65.72 |
| Genmab A/S | 32.46 |
| Zealand Pharma A/S | 46.38 |
| Cellectis SA | 3.09 |
Price Related Metrics
| PE Ratio | 20.11 |
| PS Ratio | 13.78 |
| Price to Book Value | 10.56 |
| Price to Free Cash Flow | 43.27 |
| Earnings Yield | 4.97% |
| Market Cap | 17.34B |
| Operating PE Ratio | 133.60 |
| Normalized PE Ratio | 20.11 |